Results of Whole-Brain Radiation As Salvage of Methotrexate Failure for Immunocompetent Patients With Primary CNS Lymphoma
- 1 March 2005
- journal article
- hematologic malignancies
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (7) , 1507-1513
- https://doi.org/10.1200/jco.2005.01.161
Abstract
Purpose This study evaluates the efficacy and toxicity of whole-brain radiation therapy (WBRT) as salvage therapy for immunocompetent patients who failed initial high-dose methotrexate for primary ...Keywords
This publication has 16 references indexed in Scilit:
- Treatment of Primary CNS Lymphoma With Methotrexate and Deferred Radiotherapy: A Report of NABTT 96–07Journal of Clinical Oncology, 2003
- Combination Chemotherapy and Radiotherapy for Primary Central Nervous System Lymphoma: Radiation Therapy Oncology Group Study 93-10Journal of Clinical Oncology, 2002
- Treatment for Primary CNS Lymphoma: The Next StepJournal of Clinical Oncology, 2000
- CNS LymphomaAnnals of Oncology, 1999
- Intravenous Methotrexate as Initial Treatment for Primary Central Nervous System Lymphoma: Response to Therapy and Quality of Life of PatientsJournal of Neuro-Oncology, 1999
- Long-term survival in primary CNS lymphoma.Journal of Clinical Oncology, 1998
- Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapyNeurology, 1996
- Trends in Incidence of Primary Malignant Brain Tumors in USA, 1981–1990International Journal of Epidemiology, 1995
- Non-Hodgkin's lymphoma of the brain: Can high dose, large volume radiation therapy improve survival? Report on a prospective trial by the Radiation therapy Oncology Group (RTOG): RTOG 8315International Journal of Radiation Oncology*Biology*Physics, 1992
- Response criteria for phase II studies of supratentorial malignant glioma.Journal of Clinical Oncology, 1990